Abstract:The objective of this study was to enhance the membrane permeability and anticancer effectiveness of (20S)-protopanaxadiol (PPD) by introducing triphenylphosphonium into the OH group at the C-3 site. This study shows that the anti-proliferation activity of CTPPPPD, with an IC50 value of 1.65 ± 0.10 μmol/L, was 33-times better than that of PPD (with an IC50 value of 54.56 ± 4.56 μmol/L) and superior to that of cisplatin (with an IC50 value of 1.82 ± 0.25 μmol/L) against A549 cells. Biological examinations suggested that CTPPPPD treatment reduced the growth rate of A549 cells, increased the permeability of cell membranes, and changed the structure of chromosomal DNA in a concentration-dependent manner. Annexin V/PI assay and flow cytometry were employed to detect the effect of CTPPPPD on the apoptosis of A549 cells. The results showed that CTPPPPD could induce the apoptosis of A549 cells, and the apoptosis rate of A549 cells treated with 0, 1.0, 2.0, and 4.0 μM of CTPPPPD for 24 h was 0%, 4.9%, 12.7%, and 31.0%, respectively. The integration of transcriptomics and metabolomics provided a systematic and detailed perspective on the induced antitumor mechanisms. A combined analysis of DEGs and DAMs suggested that they were primarily involved in the central carbon metabolism pathway in cancer, as well as the metabolism of aminoacyl-tRNA biosynthesis, alanine, aspartate, and glutamate. Central carbon metabolism in cancer-related genes, i.e., SLC16A3, FGFR3, LDHA, PGAM1, and SLC2A1, significantly reduced after treatment with CTPPPPD. In particular, the dominant mechanism responsible for total antitumor activity may be attributed to perturbations in the PI3K-AKT, MAPK, and P53 pathways. The findings derived from transcriptomics and metabolomics were empirically confirmed through q-PCR and molecular docking. Further analyses revealed that CTPPPPD could be a promising lead for the development of protopanaxadiol for non-small-cell lung cancer (NSCLC) drugs.

20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway.

20(S)-Protopanaxadiol Induces Human Breast Cancer MCF-7 Apoptosis Through a Caspase-Mediated Pathway

20(S)-Protopanaxadiol-induced Apoptosis in MCF-7 Breast Cancer Cell Line Through the Inhibition of PI3K/AKT/mTOR Signaling Pathway

20(S)-Protopanaxadiol induces apoptosis in human hepatoblastoma HepG2 cells by downregulating the protein kinase B signaling pathway.

20(S)-Protopanaxadiol Blocks Cell Cycle Progression by Targeting Epidermal Growth Factor Receptor.

Anti-lung Cancer Effects of Novel Ginsenoside 25-OCH3-PPD

Inhibition of 20(S)-protopanaxadiol on proliferation of lung cancer A549 cells and tumor growth of nude mice

20(S)-Protopanaxadiol Inhibits Angiotensin II-Induced Epithelial- Mesenchymal Transition by Downregulating SIRT1.

Integration of Transcriptomics and Metabolomics Reveals the Antitumor Mechanism of Protopanaxadiol Triphenylphosphate Derivative in Non-Small-Cell Lung Cancer

Anti-Tumor Activity of Three Novel Derivatives of Ginsenoside on Colorectal Cancer Cells

Effect of 20(S)-Protopanaxadiol on SMMC-7721 Human Liver Cancer in Vivo and in Vitro

Paraptosis and NF-κB activation are associated with protopanaxadiol-induced cancer chemoprevention

Effects of Polyphyllin I on Growth Inhibition of Human Non-Small Lung Cancer Cells and in Xenograft

Inductive effect of 20 (s)-proto-panaxdiol on apoptosis of human prostate cancer PC3 cells cultivated in vitro and its mechanism

Ginsenoside Ppd'S Antitumor Effect Via Down-Regulation Of Mtor Revealed By Super-Resolution Imaging

[Study on apoptosis of human lung adenocarcinoma cell line A549/DDP induced by ginsenoside Rh₂ in vitro].

25-OCH3-PPD Induces the Apoptosis of Activated T-Hsc/cl-6 Cells Via C-Flip-mediated NF-κB Activation.

Effect of 20(S)-Proto-panaxdiol on Apoptosis of Siha Cells in Vitro

Synthesis, Biological Evaluation and Mechanism Study Based on Network Pharmacology of Amino Acids Esters of 20(S)-Protopanaxadiol As Novel Anticancer Agents

PDB-1 from Potentilla discolor Bunge induces apoptosis and autophagy by downregulating the PI3K/Akt/mTOR signaling pathway in A549 cells

Anticancer Activity of Panax Notoginseng Extract 20(S)-25-OCH3-PPD: Targetting Beta-Catenin Signalling.